跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SM5-1
首页
药物
SM5-1
SM5-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Antibodies specific for cancer associated antigen SM5-1 and uses thereof
US 2005031617 A1
申请人: MA JING
优先权: 2003
US
US 2005232926 A1
申请人: ONCOMAX ACQUISITION CORP
优先权: 2004
US
High efficiency low poison immune toxin and its preparation method and application
CN 1869070 A
申请人: GUO YAJUN
优先权: 2005
CN
Magnetic resonance contrast agent based on humanized antibody for diagnosing tumor
CN 101480494 B
申请人: SHANGHAI CP GUOJIAN PHARMACEUTICAL CO LTD
优先权: 2008
CN
Poly(lactic-co-glycolic acid) nanoparticle, preparation method and application thereof
CN 102100670 A
申请人: SHANGHAI ANTIBODIES NAT ENGINEERING RES CT CO LTD
优先权: 2009
CN
Preparation and application of sour horse milk-derived lactobacillus plantarum, enterococcus faecalis and composite freeze-dried microbial inoculum with synergistic probiotic function
CN 121294270 A
申请人: ILI NALARY DAIRY GROUP CO LTD
优先权: 2025
CN
Preparation method of gepodamycin mesylate
CN 121537412 A
申请人: NANJING DAOER PHARMACEUTICAL RES INSTITUTE CO LTD
优先权: 2026
CN
药物
反馈